Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rallybio Corporaton (RLYB)

Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rallybio Corporaton 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 USA

www.rallybio.com Employees: 14 P: 203-859-3820

Sector:

Medical

Description:

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

Key Statistics

Overview:

Market Capitalization, $K 42,529
Enterprise Value, $K 11,159
Shares Outstanding, K 5,290
Float, K 4,745
% Float 89.70%
Short Interest, K 798
Short Float 15.08%
Days to Cover 1.60
Short Volume Ratio 0.72
% of Insider Shareholders 10.30%
% of Institutional Shareholders 90.34%

Financials:

Annual Sales, $ 860 K
Annual Net Income, $ -8,980 K
Last Quarter Sales, $ 220 K
Last Quarter Net Income, $ -5,850 K
EBIT, $ -33,070 K
EBITDA, $ -33,550 K

Growth:

1-Year Return 75.17%
3-Year Return -79.53%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.12 on 11/06/25
Next Earnings Date 05/14/26
Earnings Per Share ttm -4.56
EPS Growth vs. Prev Qtr 36.36%
EPS Growth vs. Prev Year 46.15%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 02/06/26

RLYB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -56.93%
Return-on-Assets % -52.67%
Profit Margin % -1,044.19%
Debt/Equity 0.00
Price/Sales 50.68
Price/Cash Flow N/A
Price/Book 0.75
Book Value/Share 10.98
Interest Coverage -0.43
60-Month Beta -1.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.